Рет қаралды 115
Lupus Forum Chair Ed Vital, from the University of Leeds, is joined by Dr Chi Chiu Mok, Chief of the Division of Rheumatology at Tuen Mun Hospital in Hong Kong. Together, they discuss the ability of obinutuzumab to preserve kidney function in patients with lupus nephritis, real-world data for telitacicept therapy, and the relationship between HCQ nonadherence and SLE disease flares.